-
Zelira Study: Cannabis Is A Safe Treatment For Non-Cancer Patients Using Opioids
Thursday, July 16, 2020 - 4:13pm | 275Read More...A recent study conducted at the St Vincent's Hospital in Melbourne, Australia, and the Emerald Clinics (EMD) in Perth, suggests cannabis is a safe option for patients to integrate into their current pain treatment. That includes patients who already consume high doses of opioids....
-
Jack Herer: A Lifelong Cannabis Advocate
Thursday, May 7, 2020 - 1:40pm | 814Read More...By Goldleaf's Alfonso Colasuonno, provided exclusively to Benzinga Cannabis. What do Jack the Ripper and Jack Skellington have in common? If you’re well-versed in cannabis culture, you’ll know that they’re both popular cultivars, and so are Sour Jack, Jack Herer, Jack...
-
Mallinckrodt Rips Higher After Company Confirms $1.6B Opioid Litigation Settlement
Tuesday, February 25, 2020 - 11:03am | 440Read More...Mallinckrodt PLC (NYSE: MNK) shares are ripping higher Tuesday after the company announced a global opioid settlement agreement that limits its payout to $1.6 billion and it aslo reported better-than-expected fourth-quarter results. Opioid Settlement Clinched, Generics Business To File For Chapter...
-
Can CBD Help With Opioid Withdrawal? Johns Hopkins Researchers Aim To Find Out By Testing Epidiolex in This Context
Tuesday, February 18, 2020 - 1:55pm | 269Read More...More than 130 people a day lose their lives from opioid-connected drug overdose, according to the Health Resources and Services Administration. Because of these and similar devastating statistics that clearly depict the real status of the opioid epidemic in the country, more and more researchers...
-
New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA
Monday, February 10, 2020 - 3:43pm | 599Read More...It appears more and more likely a case against opioid manufacturers and distributors will proceed to trial in New York state, keeping Bank of America bearish on the companies despite recent performance. The recent denial of a motion to delay the case — which the state brought against the...
-
Cannabis Companies, Veteran Organizations Team Up To Combat Suicide And Overdose Among Vets
Monday, January 27, 2020 - 4:24pm | 351Read More...Since the enactment of the adult-use cannabis legalization law in California in 2018, medical patients who relied on cannabis were faced with the disappearance of cannabis donations, enabled partly by loose regulations, and a significant rise in cost when buying from licensed shops. Veterans have...
-
New ATAI Life Sciences-DemeRx Joint Venture Seeks To Combat Opioid Use Disorder With Ibogaine
Monday, January 27, 2020 - 8:06am | 263Read More...In 2018, 2.1 million Americans met the diagnostic criteria for opioid use disorder (OUD), with 47,600 people dying from overdoses. Current treatment options for OUD are not only limited, but often carry risk of significant side effects and abuse potential. In response to this huge unmet...
-
Nektar Slumps As FDA Panel Gives Thumbs Down To Opioid Pain Drug; Program Shelved
Wednesday, January 15, 2020 - 10:07am | 353Read More...Shares of midcap biopharma Nektar Therapeutics (NASDAQ: NKTR) are retreating sharply following a negative verdict handed down by FDA staffers for its opioid pain drug. FDA Panel Flashes The Red Signal San Francisco-based Nektar said a joint sitting of the Anesthetic and Analgesic Drug Products...
-
Bruce Linton Talks Psychedelics Investments, Microdosing And LSD: 'The Therapeutic Potential Of Psychedelics Is Greater Than Cannabinoids'
Thursday, December 19, 2019 - 6:12pm | 1408Read More...Earlier this year, Canopy Growth (NYSE: CGC) co-founder and former CEO Bruce Linton invested in a neuropharmaceutical company, Mind Medicine Inc. MindMed is a psychedelic research company that’s developing non-hallucinogenic medicine from psychedelic sources. The company has also...
-
US Promotes Tech Development To Find Opioids In International Mail
Friday, December 13, 2019 - 9:51am | 742Read More...A Massachusetts company took the grand prize Dec. 12 in the Trump administration's nearly yearlong challenge to the private sector to develop efficient, nonintrusive scanning technologies to intercept dangerous illicit drugs in international mail. IDSS won $500,000 for its detection technology,...
-
Health Care ETFs Are Breaking Out, But Political Risks Linger In 2020
Wednesday, November 27, 2019 - 10:35am | 550Read More...The health care sector has shed its laggard ways as highlighted by the Health Care Select Sector SPDR (NYSE: XLV). The largest exchange traded fund dedicated to the S&P 500's second-largest sector weight is up nearly 7% this month and is flirting with a year-to-date gain of 15%. While...
-
4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain
Monday, October 21, 2019 - 9:08am | 533Read More...McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AmerisourceBergen Corp. (NYSE: ABC) have reached 11th-hour settlements to avert opioid trials in Ohio, The Wall Street Journal reported. Details were expected to emerge early...
-
Large Option Traders Aren't Buying The Johnson & Johnson Rally
Wednesday, October 16, 2019 - 3:19pm | 707Read More...Johnson & Johnson (NYSE: JNJ) shares traded higher by 2% on Wednesday on reports of potential opioid settlement negotiations, but at least a handful of large option traders aren’t optimistic that the J&J rally will last. The Trades On Wednesday morning, Benzinga Pro subscribers were...
-
Analysts, Investors Like Johnson & Johnson's Improvement, But Lawsuits Loom
Wednesday, October 16, 2019 - 2:26pm | 680Read More...Johnson & Johnson (NYSE: JNJ) stock was on the rise Wednesday following better-than-expected third-quarter earnings and guidance, but analysts are mostly leery of boosting recommendations in light of a string of legal challenges the company faces. The Analysts Morgan Stanley’s...
-
Opioid Drug Companies Rally On Hopes of Broader Settlement
Wednesday, October 16, 2019 - 11:56am | 661Read More...Shares of companies embroiled in the U.S. opioid crisis were trading sharply higher Wednesday following a Tuesday Wall Street Journal report that said three opioid drug distributors are in talks with state and local governments regarding a settlement agreement. Distributors Discuss Deal...
